A detailed history of North Star Investment Management Corp. transactions in Ocugen, Inc. stock. As of the latest transaction made, North Star Investment Management Corp. holds 300 shares of OCGN stock, worth $363. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Previous 300 -0.0%
Holding current value
$363
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 20, 2021

SELL
$6.36 - $8.51 $2,544 - $3,404
-400 Reduced 57.14%
300 $2,000
Q4 2020

Jan 12, 2021

SELL
$0.28 - $2.6 $196 - $1,820
-700 Reduced 50.0%
700 $1,000
Q4 2019

Jan 29, 2020

BUY
$0.27 - $2.19 $378 - $3,066
1,400 New
1,400 $1,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $262M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.